156 results
Page 5 of 8
8-K
EX-10.18
h8n8yu6kz1f8lc7xrc
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
1kodz7ncgkfg
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.2
sn9 3h85k
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-3.2
u9zv5sso
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
ikpvvqokjko3l8y6 hfx
21 Jun 21
Other Events
4:04pm
425
ukr6vo
21 Jun 21
Business combination disclosure
4:02pm
424B3
z9u3y6oi3 c7gjg6jf
9 Jun 21
Prospectus supplement
4:42pm
8-K
qnl s1uflpv8a4o7
9 Jun 21
Other Events
4:40pm
8-K
EX-99.1
szanrgpa oi
9 Jun 21
Other Events
4:40pm
425
EX-99.1
yj1zzm67
9 Jun 21
Business combination disclosure
4:38pm
425
twcmz5aft ymaxlf0uu
9 Jun 21
Business combination disclosure
4:38pm
8-K
EX-99.1
ksy9 v0e8ulr
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
8-K
bg379y dzp3l
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
b2bg8if
4 Jun 21
Business combination disclosure
4:20pm
425
f66sh
4 Jun 21
Business combination disclosure
4:20pm
8-K
2z9tnws hxbcs86taqsa
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
8-K
EX-99.1
3pmxpk56qg
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
lxfsx2
1 Jun 21
Business combination disclosure
4:30pm
425
EX-99.1
p4g9t jouo8
1 Jun 21
Business combination disclosure
4:30pm